All News #Library
Rare Diseases
Intercept Withdraws Ocaliva for PBC from US Market, Trial on Hold
11 Sep 2025 //
GLOBENEWSWIRE
Intercept Receives FDA Orphan Drug Designation for the Fixed-Dose Combination
16 May 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support